Skip to main content
Clinical Trials/JPRN-UMIN000047162
JPRN-UMIN000047162
Not Yet Recruiting
N/A

Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer - Biomarkers to predict irAEs in patients with NSCLC

Kobe University0 sites114 target enrollmentMay 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
on-small cell lung cancer
Sponsor
Kobe University
Enrollment
114
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2022
End Date
January 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with active double cancer (simultaneous double cancer and metachronous double cancer with no disease period within 3 years). 2\. Patients with ILD complications prior to treatment (Intestinal Lung Abnormality (ILA) is acceptable). 3\. Patients with autoimmune disease. 4\. Patients taking 10 mg or more of prednisolone. 5\. Patients who the principal investigator deems inappropriate for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials